2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19
Summary The International Initiative on Thrombosis and Cancer is an independent
academic working group of experts aimed at establishing global consensus for the treatment …
academic working group of experts aimed at establishing global consensus for the treatment …
Efficacy and safety of the non-vitamin K antagonist oral anticoagulant among patients with nonvalvular atrial fibrillation and cancer: a systematic review and network …
M Barbarawi, O Barbarawi, J Corcoran… - Current Problems in …, 2022 - Elsevier
Patients with cancer are at higher risk of atrial fibrillation (AF). Currently there are no
definitive data on clinical outcomes for nonvitamin K antagonist oral anticoagulant (NOACs) …
definitive data on clinical outcomes for nonvitamin K antagonist oral anticoagulant (NOACs) …
Risks, diagnosis, and management of recurrent cancer-associated thrombosis (CAT): a narrative review
K Dickson, K Koom-Dadzie, N Brito-Dellan… - Supportive Care in …, 2022 - Springer
This paper aims to provide a narrative review of the risks, diagnosis, and management of
recurrent venous thromboembolism (VTE) in cancer patients. There is an established …
recurrent venous thromboembolism (VTE) in cancer patients. There is an established …
[图书][B] Genesis, pathophysiology and management of venous and lymphatic disorders
N Radhakrishnan - 2022 - books.google.com
Genesis, Pathophysiology Management of Venous Diseases is the must-have resource on
venous disease. The book bridges the gap between basic science and clinical medicine …
venous disease. The book bridges the gap between basic science and clinical medicine …